Linden Capital Partners has named Alex Greeley as a partner. Previously, he worked at The Blackstone Group where he most recently served as a principal on the firm’s tactical opportunities fund.
Chicago, IL (October 11, 2021) – Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, today announced the appointment of Alex Greeley as a Partner. Mr. Greeley will be a dedicated member of the structured capital investment team, executing on the firm’s non-control strategy. Prior to Linden, Mr. Greeley spent six years with The Blackstone Group, where he served most recently as a principal in the firm’s Tactical Opportunities Fund. Mr. Greeley joins Scott Gallin as the second Structured Capital Partner. Linden closed its Structured Capital Fund earlier this year with $355 million of commitments.
“We’re thrilled to have Alex join our structured capital team,” commented Linden President and Managing Partner Tony Davis. “His experience allows us to expand our market reach in supporting healthcare business owners and sponsors with flexible solutions.”
“I am excited by the opportunity to draw on the extensive experience, relationships, and resources of the Linden platform to build a leading structured capital provider,” said Mr. Greeley. “I look forward to partnering with Tony, Scott, and the broader Linden investment and operating team.”
Mr. Greeley started his career in investment banking at Citigroup. His early career also included investment roles at First Reserve Corporation and Oaktree Capital Management. Mr. Greeley holds a Bachelor of Arts in Economics, cum laude, from Harvard College and a Master’s in Business Administration from Harvard Business School.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies. For more information, please visit www.lindenllc.com.